Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
55
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Atea Pharmaceuticals Inc market cap is $345.31M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Atea Pharmaceuticals Inc 52 week high is $6.45 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Atea Pharmaceuticals Inc 52 week low is $2.92 as of November 15, 2026.
Atea Pharmaceuticals Inc stock price today is $4.30.
Atea Pharmaceuticals Inc stock price yesterday was $4.21.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Atea Pharmaceuticals Inc's P/E ratio is -2.19.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Atea Pharmaceuticals Inc P/B ratio is 1.9653.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Atea Pharmaceuticals Inc 50-day moving average is $4.79.
